IRISBOND Hiru Eye Tracking System User Manual
- June 5, 2024
- IRISBOND
Table of Contents
Hiru
The first multi-platform eye tracker in the world
User Manual | Quick Start Guide: Windows
User Manual IRISBOND Hiru Eye Tracking System
IRISBOND CROWDBONDING, S.L. All rights reserved.
This document, including all supporting materials, is proprietary to IRISBOND
CROWDBONDING, S.L.
As this document may contain information that is confidential, proprietary, or
otherwise legally protected, it must not be further copied, distributed, or
displayed without the express written permission of IRISBOND CROWDBONDING,
S.L.
Products that are referred to in this document may be either trademarks and/or
registered trademarks of the respective owners. The publisher and the author
make no claim to these trademarks.
Contact Information
IRISBOND CROWDBONDING, S.L
Tolosa Avenue 75, 2nd floor
20018 Donostia-San Sebastián, Gipuzkoa, Spain
+34 943 496 622
Update Hiru in iOS
Check out this video for more information.
Software requirements
Hiru app needs to be at a minimum version of 2.8.
Hiru needs to have a license for iOS. If you don’t have a license for Hiru,
contact your provider.
Steps to update
In Hiru App, when a new version is available, the “Update Hiru” Button will
appear in the upper right corner in blue. Click here, then click “Upgrade
Hiru”. Leave the Hiru plugged in while the Update completes. Click “Cancel
Upgrade” to stop this process.
CE & MDR | Technical Specifications
Compliance Information: CE and MDR
Compliance Information: CE and MDR
MANUFACTURER| IRISBOND CROWDBONDING, SL VAT: ES-B75091058
ADDRESS:
AVENIDA DE TOLOSA, 75 – 2º
---|---
APPLICABLE DIRECTIVE| COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning
medical devices
HARMONIZED STANDARDS| EN 55032 (2015) / AC (2016) / A11 (2020) EN 55035
(2017):
UNE-EN 62471-1:2009
FCC CFR 47, Part 15, Subpart B (10-1-15 Edition)
ICES-003 Issue 6 (2016)
PRODUCT| Sistema de control del ordenador con la mirada HIRU/ Eye tracking
system HIRU
REFERENCE| IRISBOND HIRU
TEST CERTIFICATES| 65321IEM.001
65321REM.001
65321REM.002
2251989-PHO-21-018A
The device model has been designed and manufactured in conformity with the Directive.
Eduardo Jauregui / Technical Director
Declaration of conformity (MDR)
We, Irisbond Crowdbonding Ltd, declare that the product listed below has been
designed and manufactured in conformity with the Directive (UE) 2017/745:
MANUFACTURER| IRISBOND CROWDBONDING, SL
ES-B75091058
AVENIDA DE TOLOSA, 75 – 2º
+34 9434 96 622
http://www.irisbond.com
---|---
REFERENCE| IRISBOND HIRU
PRODUCT| Eye-tracking system HIRU
The aim of this declaration is a Class I Medical Device and is in conformity with the following harmonized legislation:
APPLICABLE DIRECTIVE| • Directive (UE) 2017/745 concerning medical devices,
MDR.
• EMC Directive, 2004/108/EC.
• RoHS Directive, 2011/65/EU.
• FCC Rules and Regulations.
---|---
The following harmonized standards and technical specifications have been applied:
HARMONIZED LEGISLATION| EN 55032 (2015) / AC (2016) / A11 (2020)
EN 55035 (2017)
UNE-EN 62471-1:2009
FCC CFR 47, Part 15, Subpart B (10-1-15 Edition)
ICES-003 Issue 6 (2016)
---|---
TEST CERTIFICATES| 65321IEM.001
65321REM.001
65321REM.002
2251989-PHO-21-018A
This declaration is signed on behalf of Irisbond Crowdbonding, Ltd in San Sebastián, on the 30th of April, 2021, by Eduardo Jauregui, CEO.
Declaration of conformity (MDR)
We, Irisbond Crowdbonding Ltd, declare that the product listed below has been
designed and manufactured in conformity with the Directive (UE) 2017/745:
MANUFACTURER| IRISBOND CROWDBONDING, SL
ES-B75091058
AVENIDA DE TOLOSA, 75 – 2
+34 9434 96 622
http://www.irisbond.com
---|---
REFERENCE| OSKOL WINDOWS
PRODUCT| This product is composed of the following elements:
• Medical device; Eye-tracking system HIRU.
• Case to bundle the Irisbond HIRU eye tracker and the Surface Pro tablet
(TPU material has PASSED skin sensitization and cytotoxicity tests in
accordance with ISO 10993-5 and 10993-10).
The aim of this declaration is a Class I Medical Device and is in conformity with the following directives:
APPLICABLE DIRECTIVE| REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND
OF THE COUNCIL of 5 April 2017 on medical devices, MRD, amending Directive
2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and
repealing Council Directive 90/385/EEC.
---|---
The following harmonized standards and technical specifications have been applied:
HARMONIZED LEGISLATION| HIRU:
EN 55032: 2015 / AC: 2016 / A11: 2020
EN 55035: 2017
UNE-EN 62471-1:2009
FCC CFR 47, Part 15, Subpart B (10-1-15 Edition)
ICES-003 Issue 6: 2016
OSKOL Windows:
ISO 10993-5
ISO 10993-10
---|---
TEST CERTIFICATES| 65321IEM.001
65321REM.001
65321REM.002
2251989-PHO-21-018A
This declaration is signed on behalf of Irisbond Crowdbonding, Ltd in San Sebastián, on the 30th of April, 2021, by Eduardo Jauregui, CEO.
Declaration of conformity (MDR)
We, Irisbond Crowdbonding Ltd, declare that the product listed below has been
designed and manufactured in conformity with the Directive (UE) 2017/745:
MANUFACTURER| IRISBOND CROWDBONDING, SL
ES-B75091058
AVENIDA DE TOLOSA, 75 – 2º
San Sebastián, 20018 Guipúzcoa, Spain
+34 9434 96 622
http://www.irisbond.com
---|---
REFERENCE| OSKOL iPad
PRODUCT
| This product is composed of the following elements:
• Eye tracking system HIRU, medical device class I.
• Case to bundle the Irisbond HIRU eye tracker and the iPad Pro tablet (TPU
material has PASSED skin sensitization and cytotoxicity tests in accordance
with ISO 10993-5 and 10993-10)
The aim of this declaration is a Class I Medical Device and is in conformity with the following harmonized legislation:
APPLICABLE DIRECTIVE| REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND
OF THE COUNCIL of 5 April 2017 concerning medical devices, MDR, amending
Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No
1223/2009 and repealing Council Directive 90/385/EEC.
---|---
The following harmonized and/or unharmonized standards and technical specifications have been applied:
HARMONIZED LEGISLATION
| HIRU:
EN 55032: 2015 / AC: 2016 / A11: 2020
EN 55035: 2017
UNE-EN 62471-1:2009
FCC CFR 47, Part 15, Subpart B (10-1-15 Edition)
ICES-003 Issue 6: 2016
OSKOL iPad:
ISO 10993-5
ISO 10993-10
---|---
TEST CERTIFICATES| 65321IEM.001
65321REM.001
65321REM.002
2251989-PHO-21-018A
This declaration is signed on behalf of Irisbond Crowdbonding, Ltd in San Sebastián, on the 30th of April, 2021, by Eduardo Jauregui, CEO.
Technical Specifications
| Optimum screen size | 10-20” |
|---|---|
| Recommended working distance | 35-80 cm. |
| Calibration | 0, 1, 5, 9, 16 points |
| Selection mode | Dwell, Blink, Switch |
| Headbox | 20 x 18 cm. at 50 cm. |
| Eye-tracking | Monocular and binocular |
| Accuracy | 0.4º |
| Sampling rate (Frequency) | 60 Hz. |
| Mounting | Holder, magnets, or specific adaptor for a consumer device |
| Operating system | Windows: 7-10 iPadOS: 13 or above Others: Please get in |
touch with us
Eye Tracking processing| Hiru on-chip eye-tracking technology
Minimum system requirements (laptop, PC, tablet)| Eye-tracking processing is
done at HIRU itself. System requirements related to the applications used with
HIRU. Typically:
• USB 3.0 -C
• 1,33 GHz CPU
• 2 GB RAM
• 3GB + HDD Hard Disk
• Intel Graphics, Nvidia, and others with OpenGL 2.0
• iOS: iPad Pro
Weight| 115 g.
Dimensions| 259 x 25 x 28 mm.
Eye-tracking technology| Dark pupil
USB connector| USB-C
See it Possible
Avenida de Tolosa, 75. Floor 2
Donostia San-Sebastián. 20018 Gipuzkoa
Spain +34 943 49 66 22
www.irisbond.com
info@irisbond.com
References
Read User Manual Online (PDF format)
Read User Manual Online (PDF format) >>